ABSTRACT
Health data is key for the development of medicinal drugs, treatments, and policy-planning to control the spread of infectious diseases. However, the collection, curation, and interpretation of health data is often biased. This paper discusses England-wide impact of public policies to control the spread of SARS-CoV-2 (Covid-19) infections, based on the recorded per-capita infection cases between July 2020 to January 2023. The analysis presented herewith highlights the disparities across the upper local tier authorities, in the number of Covid-19 cases recorded in response to the policies. This paper further presents the correlation between the Covid-19 cases count and demographic factors, thus highlighting the key factors determining the effectiveness of the NHS policies, and therefore the need for incorporating demographic imbalance in the policy planning process. It is concluded that the upper local tier authorities comprise of three clusters of low, mid, and high prevalence of Covid-19 infections. Where the regions with high prevalence of Covid-19 cases are also the ones with higher proportions of Black/ Mixed racial groups, amongst a mid-range and low internal Migrations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used for this paper can be obtained from the following two UK government websites: "https://coronavirus.data.gov.uk/details/download" and "https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets"
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
